This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Searchlight Pharma Inc.
Searchlight Pharma Inc., headquartered in California, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of innovative therapies. Founded in 2015, the company has rapidly established itself as a leader in the fields of rare diseases and specialty pharmaceuticals, focusing on areas with significant unmet medical needs. With a robust portfolio of unique products, Searchlight Pharma is dedicated to improving patient outcomes through targeted treatments. The company’s commitment to excellence is reflected in its strategic partnerships and successful product launches, which have garnered recognition within the healthcare community. As it continues to expand its operational reach across North America, Searchlight Pharma remains at the forefront of advancing healthcare solutions, solidifying its market position as a trusted provider of specialised therapies.
DitchCarbon Score
How does Searchlight Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Searchlight Pharma Inc.'s score of 34 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Searchlight Pharma Inc., headquartered in Canada, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Apotex Inc., which may influence its climate commitments and reporting practices. As of now, Searchlight Pharma Inc. has not established any documented reduction targets or initiatives related to carbon emissions. This lack of specific commitments may reflect a broader trend within the pharmaceutical industry, where many companies are still developing comprehensive climate strategies. Given the absence of direct emissions data and reduction targets, it is essential for Searchlight Pharma Inc. to consider adopting industry-standard climate initiatives, such as those outlined by the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP), to enhance its sustainability profile and align with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 44,817,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 20,870,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Searchlight Pharma Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
